BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6177990)

  • 1. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
    Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF
    Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
    Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H
    Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation.
    Keating A; Whalen CK; Singer JW
    Br J Haematol; 1983 Dec; 55(4):623-8. PubMed ID: 6200132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
    Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
    Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow macrophages and megakaryocytes express common acute lymphoblastic leukaemia antigen.
    Lai AP; Moss FM; Armitage RJ; Cawley JC
    Leuk Res; 1985; 9(9):1155-9. PubMed ID: 2933564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.
    Ritz J; Sallan SE; Bast RC; Lipton JM; Nathan DG; Schlossman SF
    Haematol Blood Transfus; 1983; 28():117-23. PubMed ID: 6345287
    [No Abstract]   [Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure.
    Ito T; Ishikawa Y; Noda M; Fujii R
    Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.
    Ramsay N; LeBien T; Nesbit M; McGlave P; Weisdorf D; Kenyon P; Hurd D; Goldman A; Kim T; Kersey J
    Blood; 1985 Sep; 66(3):508-13. PubMed ID: 3896344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
    Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
    Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).
    Hokland P; Rosenthal P; Griffin JD; Nadler LM; Daley J; Hokland M; Schlossman SF; Ritz J
    J Exp Med; 1983 Jan; 157(1):114-29. PubMed ID: 6571733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies.
    Fried J; Perez AG; Shimazaki C; Clarkson BD
    Exp Cell Biol; 1987; 55(6):322-30. PubMed ID: 2453381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia.
    Racadot E; Herve P; Lamy B; Peters A
    Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
    Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.
    Netzel B; Haas RJ; Rodt H; Kolb HJ; Thierfelder S
    Lancet; 1980 Jun; 1(8182):1330-2. PubMed ID: 6104132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and modulation of a human leukemia-associated antigen (CALLA).
    Pesando JM; Tomaselli KJ; Lazarus H; Schlossman SF
    J Immunol; 1983 Oct; 131(4):2038-45. PubMed ID: 6225802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
    Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
    Goldmacher VS; Lambert JM; Young AY; Anderson J; Tinnel NL; Kornacki M; Ritz J; Blättler WA
    J Immunol; 1986 Jan; 136(1):320-5. PubMed ID: 2415623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.